All persons who purchased or otherwise acquired common stock or options to purchase common stock of Corcept Therapeutics Incorporated during the Settlement Class Period, August 2, 2017 to January 31, 2019, inclusive.
Preliminarily Approved
August 02, 2017 - January 31, 2019
June 06, 2024
May 13, 2024
Corcept Therapeutics Incorporated Securities Litigation Claims Administrator c/o A.B. Data, Ltd. P.O. Box 173029 Milwaukee, WI 53217 info@CorceptSecuritiesLitigation.com Telephone: (877) 390-3297
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.